Gene Editing Medical Animations

Demystify gene editing. We transform complex genomic science into accurate, visually stunning narratives.

BACK

EDIT-301 MOA: GENE EDITING FOR SICKLE CELL DISEASE AND BETA-THALASSEMIA

OPEN

CLOSE

This Fusion Animation uses 3D medical animation to illustrate the Mechanism of Action (MOA) of EDIT-301, a gene-editing medicine for Sickle Cell Disease (SCD) and Beta-Thalassemia (TDT). The video visualizes the pathophysiology and shows how EDIT-301 uses a nuclease to edit the fetal hemoglobin gene promoter. This drives the sustained production of fetal hemoglobin, correcting anemia. This showcases our expertise in Gene Therapy and Hematology.

0:00

EDIT-301 MOA: GENE EDITING FOR SICKLE CELL DISEASE AND BETA-THALASSEMIA

This Fusion Animation uses 3D medical animation to illustrate the Mechanism of Action (MOA) of EDIT-301, a gene-editing medicine for Sickle Cell Disease (SCD) and Beta-Thalassemia (TDT). The video visualizes the pathophysiology and shows how EDIT-301 uses a nuclease to edit the fetal hemoglobin gene promoter. This drives the sustained production of fetal hemoglobin, correcting anemia. This showcases our expertise in Gene Therapy and Hematology.

OPTI-OX: ENGINEERING HUMAN CELLS WITH A SOFTWARE APPROACH TO BIOLOGY

OPEN

CLOSE

This Fusion Animation details bit.bio's revolutionary opti-ox™ technology for cell manufacturing. We used a minimalist style to show the cell as a computer, and how opti-ox overcomes gene silencing by inserting new programs into Genomic Safe Harbour sites. This proprietary method enables the deterministic, scalable manufacturing of pure human cells (e.g., ioGlutamatergic Neurons) for drug discovery and cell therapies. This showcases our expertise in Cell Reprogramming and Biotechnology

0:00

OPTI-OX: ENGINEERING HUMAN CELLS WITH A SOFTWARE APPROACH TO BIOLOGY

This Fusion Animation details bit.bio's revolutionary opti-ox™ technology for cell manufacturing. We used a minimalist style to show the cell as a computer, and how opti-ox overcomes gene silencing by inserting new programs into Genomic Safe Harbour sites. This proprietary method enables the deterministic, scalable manufacturing of pure human cells (e.g., ioGlutamatergic Neurons) for drug discovery and cell therapies. This showcases our expertise in Cell Reprogramming and Biotechnology

OPEN

CLOSE

0:00

OPEN

CLOSE

0:00

Contact

Please contact us using the details below.

Office

410, Highgate Studios,
53-79 Highgate Road,
London NW5 1TL0

T +44 (0)207 127 6935

+44 (0)207 127 6935

M +44 (0)7970 080 690

+44 (0)7970 080 690

info@fusionanimation.co.uk

info@fusionanimation.co.uk

SOCIAL

Vimeo

Viemo

Instagram

Instagram

LinkedIn

LinkedIn
SUBMIT
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CLOSE